Investigational Drug Information for N,N-Dimethyltryptamine
✉ Email this page to a colleague
What is the development status for investigational drug N,N-Dimethyltryptamine?
N,N-Dimethyltryptamine is an investigational drug.
There have been 31 clinical trials for N,N-Dimethyltryptamine.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 11th 2019.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Depressive Disorder, Major. The leading clinical trial sponsors are Johns Hopkins University, Universidade Federal do Rio Grande do Norte, and University Hospital, Basel, Switzerland.
There are ninety-eight US patents protecting this investigational drug and zero international patents.
Summary for N,N-Dimethyltryptamine
US Patents | 98 |
International Patents | 1,044 |
US Patent Applications | 509 |
WIPO Patent Applications | 295 |
Japanese Patent Applications | 43 |
Clinical Trial Progress | Phase 2 (2019-03-11) |
Vendors | 20 |
Recent Clinical Trials for N,N-Dimethyltryptamine
Title | Sponsor | Phase |
---|---|---|
Acute Analgesic Effects of DMT on Experimentally Induced Pain in Healthy Participants | University Hospital, Basel, Switzerland | Phase 1 |
Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression | Universidade Federal do Rio Grande do Norte | Phase 2 |
Safety and Tolerability of DMT in Healthy Adults | Universidade Federal do Rio Grande do Norte | Phase 1 |
Clinical Trial Summary for N,N-Dimethyltryptamine
Top disease conditions for N,N-Dimethyltryptamine
Top clinical trial sponsors for N,N-Dimethyltryptamine
US Patents for N,N-Dimethyltryptamine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
N,N-Dimethyltryptamine | ⤷ Sign Up | Methods of improving behavioral therapies | Emory University (Atlanta, GA) | ⤷ Sign Up |
N,N-Dimethyltryptamine | ⤷ Sign Up | Complex and structurally diverse compounds | The Board of Trustees of the University of Illinois (Urbana, IL) | ⤷ Sign Up |
N,N-Dimethyltryptamine | ⤷ Sign Up | Pharmaceutical compositions resistant to abuse | EGALET LTD. (London, GB) | ⤷ Sign Up |
N,N-Dimethyltryptamine | ⤷ Sign Up | Formulations of histone deacetylase inhibitor and uses thereof | Pharmacyclics LLC (Sunnyvale, CA) | ⤷ Sign Up |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for N,N-Dimethyltryptamine
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
N,N-Dimethyltryptamine | World Intellectual Property Organization (WIPO) | WO2013142873 | 2032-03-23 | ⤷ Sign Up |
N,N-Dimethyltryptamine | European Patent Office | EP3134408 | 2034-04-22 | ⤷ Sign Up |
N,N-Dimethyltryptamine | World Intellectual Property Organization (WIPO) | WO2015164308 | 2034-04-22 | ⤷ Sign Up |
N,N-Dimethyltryptamine | Australia | AU2010211376 | 2029-02-06 | ⤷ Sign Up |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |